PL
Pagari Life Science Corp.
SEC filingPharmaceuticals · Bethalta, IL
Amount raised$97Ksold at filing
Total offering$300K$203K still open
Investors in the raise8count reported to the SEC
FiledMay 12, 2026first sale Apr 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
James WickenhauserExecutive Officer
Marni ZenkewiczExecutive Officer
David FeldkerExecutive Officer, Director
Stephen PeipertExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.